{"id":2108,"date":"2022-03-14T10:05:06","date_gmt":"2022-03-14T13:05:06","guid":{"rendered":"https:\/\/ri-alliar2020.mz-sites.com\/noticias\/pesquisa-com-os-acionistas-controladores\/"},"modified":"2022-07-04T13:48:45","modified_gmt":"2022-07-04T16:48:45","slug":"survey-with-controlling-shareholders","status":"publish","type":"noticias","link":"https:\/\/ri.allianca.com\/en\/noticias\/survey-with-controlling-shareholders\/","title":{"rendered":"Survey with Controlling Shareholders"},"content":{"rendered":"

CENTRO DE IMAGEM DIAGNOSTICS S.A.<\/strong>\u00a0(“Company”. “Alliar”) (B3: AALR3) in compliance with art. 157, \u00a7 4, of Law No. 6.404, of December 15, 1976, as amended and to the provisions of Securities Commission Resolution No. 44, of August 23, 2021, informs its shareholders and the market, that on March 11, 2022 it received, for disclosure to the market, a copy of the letter sent by the representatives of the shareholders of the Company\u2018s control block, signatories of the shareholders\u2018 agreement executed on August 20, 2021, as amended (“Controlling Shareholders”) to Fonte de Sa\u00fade Fundo de Investimento em Participa\u00e7\u00f5es Multiestrat\u00e9gia (“Buyer”) containing a survey of Controlling Shareholders, in order to have an indication of (i) the number of shares that each selling shareholder, in accordance with the Agreement for the Purchase and Sale of Shares and Other Covenants entered into on December 21, 2021 (“Agreement”), intends to sell at the closing of the purchase and sale transaction, and (ii) the number of shares that each selling shareholder wants to bind to to Alliar share put option agreement referred to in the Agreement.<\/p>\n

In this regard, the letter informs the following consolidated result of the research, on that date:<\/p>\n

(a) total number of shares object of the purchase and sale: 57,009,219 shares, representing 48.19% of the shares issued by Alliar;<\/p>\n

(b) total number of shares subject to the put option: 5,391,623 shares, representing 4.56% of the shares issued by Alliar;<\/p>\n

(c) total number of free and unencumbered shares at this time to be sold in the purchase and sale: 50,154,878 shares, representing 42.40% of the shares issued by Alliar and 87.97% of the shares referred to in item (a) above; and<\/p>\n

(d) total number of shares that are still encumbered at this time and that, in order to be effectively sold in the purchase and sale, must be free and unencumbered in accordance with the provisions of the Agreement: 6,860,121 shares, representing 5.80% of the shares issued by Alliar and 12.03% of the shares referred to in item (a) above<\/p>\n

The entire contents of the letter can be found as\u00a0Attachment I<\/strong>\u00a0to this material fact<\/p>\n

The Company reiterates its commitment to keep the market informed about material facts and acts, in compliance with applicable regulations.<\/p>\n

S\u00e3o Paulo, March 14, 2022.<\/p>\n

To access the full document,\u00a0click here<\/a>.<\/p>\n

Karla Maciel<\/strong>
\nCEO & IRO
\nE-mail:\u00a0ri@alliar.com<\/a><\/p>\n","protected":false},"featured_media":0,"template":"","class_list":["post-2108","noticias","type-noticias","status-publish","hentry"],"yoast_head":"\nSurvey with Controlling Shareholders - Allian\u00e7a RI<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ri.allianca.com\/en\/noticias\/survey-with-controlling-shareholders\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Survey with Controlling Shareholders - Allian\u00e7a RI\" \/>\n<meta property=\"og:description\" content=\"CENTRO DE IMAGEM DIAGNOSTICS S.A.\u00a0(“Company”. “Alliar”) (B3: AALR3) in compliance with art. 157, \u00a7 4, of Law No. 6.404, of December 15, 1976, as amended and to the provisions of Securities Commission Resolution No. 44, of August 23, 2021, informs its shareholders and the market, that on March 11, 2022 it received, for disclosure to […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ri.allianca.com\/en\/noticias\/survey-with-controlling-shareholders\/\" \/>\n<meta property=\"og:site_name\" content=\"Allian\u00e7a RI\" \/>\n<meta property=\"article:modified_time\" content=\"2022-07-04T16:48:45+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ri.allianca.com\/en\/noticias\/survey-with-controlling-shareholders\/\",\"url\":\"https:\/\/ri.allianca.com\/en\/noticias\/survey-with-controlling-shareholders\/\",\"name\":\"Survey with Controlling Shareholders - Allian\u00e7a RI\",\"isPartOf\":{\"@id\":\"https:\/\/ri.allianca.com\/#website\"},\"datePublished\":\"2022-03-14T13:05:06+00:00\",\"dateModified\":\"2022-07-04T16:48:45+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/ri.allianca.com\/en\/noticias\/survey-with-controlling-shareholders\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ri.allianca.com\/en\/noticias\/survey-with-controlling-shareholders\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ri.allianca.com\/en\/noticias\/survey-with-controlling-shareholders\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\/\/ri.allianca.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Survey with Controlling Shareholders\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ri.allianca.com\/#website\",\"url\":\"https:\/\/ri.allianca.com\/\",\"name\":\"Allian\u00e7a RI\",\"description\":\"Rela\u00e7\u00f5es com Investidores\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ri.allianca.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Survey with Controlling Shareholders - Allian\u00e7a RI","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ri.allianca.com\/en\/noticias\/survey-with-controlling-shareholders\/","og_locale":"en_US","og_type":"article","og_title":"Survey with Controlling Shareholders - Allian\u00e7a RI","og_description":"CENTRO DE IMAGEM DIAGNOSTICS S.A.\u00a0(“Company”. “Alliar”) (B3: AALR3) in compliance with art. 157, \u00a7 4, of Law No. 6.404, of December 15, 1976, as amended and to the provisions of Securities Commission Resolution No. 44, of August 23, 2021, informs its shareholders and the market, that on March 11, 2022 it received, for disclosure to […]","og_url":"https:\/\/ri.allianca.com\/en\/noticias\/survey-with-controlling-shareholders\/","og_site_name":"Allian\u00e7a RI","article_modified_time":"2022-07-04T16:48:45+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/ri.allianca.com\/en\/noticias\/survey-with-controlling-shareholders\/","url":"https:\/\/ri.allianca.com\/en\/noticias\/survey-with-controlling-shareholders\/","name":"Survey with Controlling Shareholders - Allian\u00e7a RI","isPartOf":{"@id":"https:\/\/ri.allianca.com\/#website"},"datePublished":"2022-03-14T13:05:06+00:00","dateModified":"2022-07-04T16:48:45+00:00","breadcrumb":{"@id":"https:\/\/ri.allianca.com\/en\/noticias\/survey-with-controlling-shareholders\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ri.allianca.com\/en\/noticias\/survey-with-controlling-shareholders\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ri.allianca.com\/en\/noticias\/survey-with-controlling-shareholders\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/ri.allianca.com\/en\/"},{"@type":"ListItem","position":2,"name":"Survey with Controlling Shareholders"}]},{"@type":"WebSite","@id":"https:\/\/ri.allianca.com\/#website","url":"https:\/\/ri.allianca.com\/","name":"Allian\u00e7a RI","description":"Rela\u00e7\u00f5es com Investidores","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ri.allianca.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/ri.allianca.com\/en\/wp-json\/wp\/v2\/noticias\/2108","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ri.allianca.com\/en\/wp-json\/wp\/v2\/noticias"}],"about":[{"href":"https:\/\/ri.allianca.com\/en\/wp-json\/wp\/v2\/types\/noticias"}],"wp:attachment":[{"href":"https:\/\/ri.allianca.com\/en\/wp-json\/wp\/v2\/media?parent=2108"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}